However, the expression of CD44 was also found to be negatively associated with tumor invasiveness and Gleason grades, which is mainly related to the switch between CD44s and CD44v on the cancer cells through alternative splicing of CD44 isoforms. This evidence concerns the gene CD44 and cancer.